ET A and ET B Receptors Mediate Contraction to Endothelin-1 in Renal Artery of Aging SHR
- 1 April 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 25 (4), 501-506
- https://doi.org/10.1161/01.hyp.25.4.501
Abstract
We characterized vascular endothelin receptors of the renal artery from adult (12 to 16 weeks of age) and old (72 to 76 weeks) spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto rats (WKY). Vessels were suspended in organ chambers (37°C, aerated with 95% O 2 /5% CO 2 ), and isometric tension was recorded. The endothelin-A (ET A ) receptor antagonist FR139317, the combined ET A /ET B receptor antagonist bosentan, and the ET B -selective agonist sarafotoxin S6c were used. In old (and less so in adult) SHR, cumulative concentration-contraction curves to endothelin-1 showed a small contraction resistant to FR139317 (10 −5 mol/L) at 3×10 −9 to 10 −8 mol/L endothelin-1, which was completely inhibited by bosentan (10 −5 mol/L). This FR139317-resistant contraction to endothelin-1 was not present in WKY. Furthermore, in the presence of FR139317 (10 −5 mol/L), sarafotoxin S6c induced a stronger contraction in old SHR than in WKY ( P <.05). In rings contracted with norepinephrine, sarafotoxin S6c caused endothelium-dependent relaxations in both strains; these relaxations were blocked by N ω -nitro- l -arginine methyl ester, indicating that nitric oxide is the mediator. In WKY but not SHR, release of nitric oxide by sarafotoxin S6c increased with age ( P <.05). Thus, both ET A and ET B receptors mediate contraction to endothelin-1 in the renal artery from SHR but not WKY. ET B receptors on vascular smooth muscle seem to be unmasked with age in SHR, whereas those on endothelium (mediating nitric oxide release) exhibit more efficient responses with age in WKY.Keywords
This publication has 40 references indexed in Scilit:
- Characterization of Contractile Endothelin and Angiotensin Receptors in Human Resistance Arteries: Evidence for Two Endothelin and One Angiotensin ReceptorBiochemical and Biophysical Research Communications, 1994
- Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive modelLife Sciences, 1993
- Potential role of endothelin in hypertension. Controversy on endothelin in hypertension.Hypertension, 1993
- Role of endothelium in endothelin-evoked contractions in the rat aorta.Hypertension, 1993
- Pharmacologic Characterization of an EndothelinA (ETA) Receptor Antagonist in Conscious RatsJournal of Cardiovascular Pharmacology, 1992
- Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction.Hypertension, 1991
- Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Phosphoramidon Blocks the Pressor Activity of Big Endothelin[1–39] and Lowers Blood Pressure in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1991
- Increased Plasma Endothelin Level in Patients with Essential HypertensionNew England Journal of Medicine, 1990
- Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats.Hypertension, 1989